Conference Coverage

Watchman device hits home run in PROTECT AF trial


 

AT HEART RHYTHM 2013

A fifth and final year of follow-up is scheduled for the PROTECT AF study.

The trial is sponsored by Boston Scientific. Dr. Reddy reported serving as a consultant to or receiving research grant support from Boston Scientific, Coherex Medical, and St. Jude Medical.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Long detection cuts inappropriate shocks from ICDs
MDedge Cardiology
Dietary antioxidants linked to reduced postoperative atrial fib
MDedge Cardiology
Less aggressive anticoagulation appears safe after high-risk aortic valve replacement
MDedge Cardiology
Single-chamber ICDs better when pacing isn't required
MDedge Cardiology
Antitachycardia pacing in ICDs linked to higher mortality
MDedge Cardiology
Biventricular pacing bests conventional tx in BLOCK HF trial
MDedge Cardiology
BRUISE CONTROL: Continue warfarin during cardiac device surgery
MDedge Cardiology
Upcoming guidelines on inherited arrhythmias contain surprises
MDedge Cardiology
DECAAF points way to improved AF ablation
MDedge Cardiology
Renal dysfunction improved after AF ablation
MDedge Cardiology